|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2010-8-16
|
|
pubmed:abstractText |
Aortic stenosis (AS) is associated with significant morbidity and mortality. Recombinant apolipoprotein A-I Milano (rApoA-I(M)) induces atherosclerotic plaque regression. The aims of this study were to determine the effects of rApoA-I(M) on experimental aortic valve degeneration and its mechanisms of action.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1522-9645
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2049-57
|
|
pubmed:meshHeading |
pubmed-meshheading:20304838-Alkaline Phosphatase,
pubmed-meshheading:20304838-Animals,
pubmed-meshheading:20304838-Anti-Inflammatory Agents,
pubmed-meshheading:20304838-Aortic Valve Stenosis,
pubmed-meshheading:20304838-Apolipoprotein A-I,
pubmed-meshheading:20304838-Calcinosis,
pubmed-meshheading:20304838-Myofibroblasts,
pubmed-meshheading:20304838-Plaque, Atherosclerotic,
pubmed-meshheading:20304838-Rabbits,
pubmed-meshheading:20304838-Random Allocation,
pubmed-meshheading:20304838-Recombinant Proteins
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model.
|
|
pubmed:affiliation |
Atherothrombosis Research Unit, Mount Sinai School of Medicine New York, NY, USA.
|
|
pubmed:publicationType |
Journal Article
|
